30 results about "Glandular secretion" patented technology

The invention discloses dsRNA (double-stranded Ribose Nucleic Acid) for inhibiting expression of a salivary glandular secretion polypeptide gene of wheat aphids and application thereof. The invention provides a dsRNA molecule which is as shown in a sequence 2 in a sequence table. The invention also protects a DNA (Deoxyribose Nucleic Acid) molecule for encoding the RNA molecule. The invention also protects application of the RNA molecule or the DNA molecule. The application comprises at least one of the following application: (1) preventing and treating aphids; (2) promoting death of the aphids; (3) inhibiting the aphids from growing; (4) inhibiting expression of the in-vivo salivary glandular secretion polypeptide gene of the aphids. The dsRNA and the application thereof have important application value for preventing and treating the aphids in the agricultural production.

A method of modulating glandular secretions by administering acoustic shock waves to a gland, includes the steps of activating acoustic shock waves of an acoustic shock wave generator to emit acoustic shock waves and subjecting the gland to acoustic shock waves stimulating the gland to have a modulated response. The modulated response is one of an adjustment in hormonal release which increases low level output, decreases high level output or stabilizes erratic output. The emitted acoustic shock waves are focused or unfocused low energy acoustic shock waves. The gland underlies the patient's skin. The shock wave generator is acoustically coupled to the patient's skin using a coupling gel or liquid. The gland is one of a testicle, ovary, pituitary gland, adrenal gland, thyroid gland, thymus, pineal gland, parathyroid, or hypothalamus. The method can be repeated one or more times.

An organ chip unit containing a pipeline network, comprising: at least one layer of chips containing an input pipeline network for the input, diversion and diffusion of substances; at least one layer of chips containing an output pipeline network for Diffusion, confluence and output of substances; at least one layer of chamber chips, containing solid organ tissues; at least two layers of microporous membranes, separated by microporous membranes between solid organ tissues and input and output pipeline networks; at least Two layers of barrier cells, the barrier cells are in the input and output pipeline network, adhered to the microporous membrane; two layers of sealing plates are used to realize encapsulation. Using the organ chip unit, it is possible to simulate the process that substances enter the tissue after being shunted through various pipeline networks such as blood vessels / lymphatic vessels / bronchial / gland secretion network, and then gradually converge after being metabolized in the tissue. At the same time, it is more accurate when applied to drug screening, case study and physiological analysis.

The invention relates to an aweto medicated wine and process for preparation, which belongs to the nourishing and health preserving field. The invention comprises aweto, poria cocos, Chinese yam, eucommia ulmoides, alpinia oxyphylla, wolfberry fruit, radix adenophorea, cuscuta chinensis, liriope, tortoises shell, sucrose and sorghum wine whose alcohol is 42-54 degrees (v / v). In the process of preparation, the herbal medicines are immersed in the wine, and sealed to store for 30-50 days at normal temperature, then solid and liquid-state admixture is separated, and the supernatant which is obtained is a desired product. The invention has no toxin and side effect, and has the functions of moistening lung to stop coughing, nourishing liver and kidney, replenishing essence to improve vision, strengthening essence to invigorate vital energy, nourishing yin and promoting glandular secretion, nourishing spleen and strengthening stomach, anchoring mind and diuretic, lowering blood pressure anddecreasing blood glucose, reinforcing blood circulation and the like. The invention can be used not only for health care but also for treatment.

The invention discloses a medicinal composition for treating perimenopausal xerophthalmia. The medicinal composition has the innovative structure shown in the description. The medicine provided by the invention can obviously improve the dry eye SIT caused by decrease of the perimenopausal gonadal hormone concentrations, change the tear protein components, promote the eyelid glandular secretion, and effectively reduce the inflammatory cell infiltration of the androgen dysfunctional xerophthalmia and the basal cellular atrophy of the corneal epithelium, belongs to a medicine which is safe and effective, has the simple administration route, has small side effects, and can be used by patients for a long term in treating the dry eye disease, and therefore, the medicinal composition has the wide clinical application and promotion values.

The invention discloses a new process for preparing a traditional Chinese medicine belladonna liquid extract. The belladonna liquid extract is a domestic widely-used plant intermediate and clinically mainly used for gastric acid duodenal ulcer, angina of gastrointestinal tract, kidney and gallbladder and the like and has functions of removing smooth muscle spasm, restraining glandular secretion and the like. Original medicinal materials of the belladonna liquid extract are belladonna herb, and the belladonna herb is whole herb of Atropa belladonna L. A current main preparation method of the belladonna liquid extract is a percolation method, and the percolation method is long in consuming time, more in solvent consumption and insufficient in effective component enrichment. The invention discloses a process for preparing the belladonna liquid extract by ultrasonic dynamic multi-stage countercurrent extraction based on the conditions. According to the process, effective plant components are sufficiently extracted by the aid of ultrasonic cavitation effect, the dynamic multi-stage countercurrent extraction saves energy, and organic solvents are circularly used, so that the belladonna liquid extract is rapidly and effectively prepared. According to the process, an ultrasonic method is used in a dynamic multi-stage countercurrent extraction system for the first time.

The invention discloses a Chinese medicine preparation used for treating gynecological and andrology diseases; the Chinese medicine preparation is composed of the raw materials according to the following proportion by weight: 5-7 parts of tuckahoe, 3-5 parts of bryozoatum and 0.5-1.5 parts of talcum; the Chinese medicine preparation can be prepared into ointment, and the preparation method is as follows: all raw materials are taken according to the formulation and pulverized into 120 mesh fine powder, and after being evenly mixed, the fine powder is added with pharmaceutically acceptable carrier for decocting so as to prepare the ointment. The Chinese medicine preparation of the invention has not only the efficacies of clearing away heat and toxic material, resisting bacteria, diminishing inflammation, eliminating dampness, relieving itching, promoting granulation and preventing necrosis, but also the functions of repairing vaginal muscular cells, promoting the regeneration of vaginal muscular cells, facilitating glandular secretion, contracting the vagina, and restoring the elasticity of vaginal smooth muscles; moreover, the Chinese medicine preparation has the advantages of low cost, simple preparation method, significant curative effects and no toxic and side effects.